Regulation of vascular endothelial cell growth factor expression in mouse mammary tumor cells by the EP2 subtype of the prostaglandin E2 receptor
- 31 May 2005
- journal article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 76 (1-4) , 48-58
- https://doi.org/10.1016/j.prostaglandins.2004.12.001
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δCancer Cell, 2004
- Cyclooxygenase-2 Induces EP1- and HER-2/Neu-Dependent Vascular Endothelial Growth Factor-C Up-RegulationCancer Research, 2004
- Cyclooxygenase 2-derived prostaglandin E 2 regulates the angiogenic switchProceedings of the National Academy of Sciences, 2004
- Role of prostaglandin E 2 -dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progressionProceedings of the National Academy of Sciences, 2003
- Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor GrowthThe Journal of Experimental Medicine, 2003
- Prostaglandin E2 Induces Hypoxia-inducible Factor-1α Stabilization and Nuclear Localization in a Human Prostate Cancer Cell LineJournal of Biological Chemistry, 2002
- The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritisJournal of Clinical Investigation, 2002
- Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout miceNature Medicine, 2001
- Prostanoid Receptors: Subtypes and SignalingAnnual Review of Pharmacology and Toxicology, 2001
- RATIONAL PLANNING OR MUDDLING THROUGH?The Lancet, 1977